Applied Finance Capital Management, LLC Biogen Inc. Transaction History
Applied Finance Capital Management, LLC
- $2.34 Trillion
- Q3 2024
A detailed history of Applied Finance Capital Management, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Applied Finance Capital Management, LLC holds 2,017 shares of BIIB stock, worth $350,796. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,017
Previous 3,362
40.01%
Holding current value
$350,796
Previous $779 Million
16.36%
% of portfolio
0.04%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding BIIB
# of Institutions
1,016Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.89 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.84 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.53 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.23 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$988 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...